2m 2m 2m 2m 2m 2m 2m
Incyte (INCY)
NASDAQ
$115.62+$0.32 (+0.28%)
Price as of Oct 02, 2026 7:45 PM EDT- $23.7BMarket Cap
- 32.76%1-Year Change
- BiotechnologyIndustry
Incyte (INCY)
$115.62+$0.32 (+0.28%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BAKER BROS. ADVISORS LP | 15.18% | 30.8M | +17,918 (+0.06%) | Jun 30, 2026 |
BLACKROCK INC. | 10.54% | 21.4M | -1.9M (-8.82%) | Jun 30, 2024 |
VANGUARD GROUP INC | 9.82% | 19.9M | -40,189 (-0.20%) | Dec 31, 2025 |
BLACKROCK, INC. | 8.90% | 18.0M | -945,480 (-5.24%) | Jun 30, 2026 |
BLACKROCK FUNDING, INC. /DE | 8.15% | 16.5M | -567,293 (-3.44%) | Dec 31, 2024 |
DODGE & COX | 5.90% | 12.0M | -295,030 (-2.47%) | Jun 30, 2026 |
VANGUARD CAPITAL MANAGEMENT LLC | 5.44% | 11.0M | +94,223 (+0.85%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FS Series Trust | 8.09% | 16.4M | 0 (0.00%) | Mar 31, 2022 |
VANGUARD INDEX FUNDS | 7.83% | 15.9M | +170,300 (+1.07%) | Jun 30, 2026 |
DODGE & COX FUNDS | 4.67% | 9.5M | -393,100 (-4.15%) | Jun 30, 2026 |
INVESCO EXCHANGE-TRADED FUND TRUST | 1.45% | 2.9M | +155,899 (+5.31%) | Jul 31, 2026 |
INVESCO QQQ TRUST, SERIES 1 | 1.42% | 2.9M | 0 (0.00%) | Jun 30, 2026 |
VANGUARD SPECIALIZED FUNDS | 1.18% | 2.4M | +20,581 (+0.86%) | Jul 31, 2026 |
T. Rowe Price Blue Chip Growth Fund, Inc. | 1.02% | 2.1M | 0 (0.00%) | Jun 30, 2026 |
Current Ownership Distribution
- Institutions3.9B (77.97%)
- Mutual Funds1.1B (21.30%)
- Insiders36.4M (0.73%)
- Other0 (0.00%)
Insider Transactions
- 0.73% (36.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 8Number of InsiderSelling (last 12 months)
- $333.4MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
BAKER BROS. ADVISORS LP | Award | Sep 30, 2026 | $0.00 | 322 | $0.00 | 2.8M |
HARRIGAN EDMUND | Award | Sep 30, 2026 | $24,998.10 | 206 | $121.35 | 23,225 |
BAKER BROS. ADVISORS LP | Award | Sep 30, 2026 | $0.00 | 322 | $0.00 | 28.2M |
Clancy Paul J | Award | Sep 30, 2026 | $24,634.05 | 203 | $121.35 | 25,838 |
Gardner David H EVP, Chief Strategy Officer | In Kind | Sep 22, 2026 | $116,775.60 | 920 | $126.93 | 15,904 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $0.00 | 2,957 | $0.00 | 4,225 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $0.00 | 4,551 | $0.00 | 4,551 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $0.00 | 6,477 | $0.00 | 20,356 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $0.00 | 9,233 | $0.00 | 18,466 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $182,624.32 | 2,957 | $61.76 | 186,157 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $278,430.18 | 4,551 | $61.18 | 190,708 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $416,147.25 | 6,477 | $64.25 | 197,185 |
CAGNONI PABLO J President, Global Head of R&D | Exempt | Sep 15, 2026 | $664,129.69 | 9,233 | $71.93 | 206,418 |
CAGNONI PABLO J President, Global Head of R&D | Sell | Sep 15, 2026 | $1.1M | 9,233 | $120.50 | 197,185 |
CAGNONI PABLO J President, Global Head of R&D | Sell | Sep 15, 2026 | $1.7M | 13,985 | $120.49 | 183,200 |
Basi Ramitpal K EVP, Human Resources | In Kind | Aug 25, 2026 | $65,378.88 | 504 | $129.72 | 10,993 |
CAGNONI PABLO J President, Global Head of R&D | Sell | Aug 19, 2026 | $1.4M | 10,801 | $125.56 | 183,200 |
CAGNONI PABLO J President, Global Head of R&D | Sell | Aug 12, 2026 | $1.3M | 10,803 | $120.04 | 194,001 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Aug 05, 2026 | $0.00 | 2,207 | $0.00 | 0 |
CAGNONI PABLO J President, Global Head of R&D | Sell | Aug 05, 2026 | $1.3M | 10,640 | $122.69 | 204,804 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Aug 05, 2026 | $234,979.29 | 2,207 | $106.47 | 63,648 |
Mayes Patrick A EVP & Chief Scientific Officer | Sell | Aug 05, 2026 | $273,645.93 | 2,207 | $123.99 | 61,441 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Aug 03, 2026 | $638,378.65 | 6,055 | $105.43 | 67,496 |
Mayes Patrick A EVP & Chief Scientific Officer | Sell | Aug 03, 2026 | $729,203.65 | 6,055 | $120.43 | 61,441 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Aug 03, 2026 | $0.00 | 6,055 | $0.00 | 0 |
CAGNONI PABLO J President, Global Head of R&D | Sell | Jul 31, 2026 | $1.9M | 15,888 | $119.70 | 215,444 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Jul 31, 2026 | $178,523.24 | 2,918 | $61.18 | 66,546 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Jul 31, 2026 | $146,747.00 | 2,284 | $64.25 | 68,830 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Jul 31, 2026 | $167,307.84 | 2,709 | $61.76 | 71,539 |
Mayes Patrick A EVP & Chief Scientific Officer | Exempt | Jul 31, 2026 | $216,015.76 | 3,148 | $68.62 | 74,687 |